Initial surgery versus conservative management of symptomatic severe mitral regurgitation in the elderly

Heart, Artery and Coronary Diseases

Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study

Lancet.

Praz F, Spargias K, Chrissoheris M, Büllesfeld L, Nickenig G, Deuschl F, Schueler R, Fam NP, Moss R, Makar M, Boone R, Edwards J, Moschovitis A, Kar S, Webb J, Schäfer U, Feldman T, Windecker S

doi: 10.1016/S0140-

Heart, Artery and Coronary DiseasesHeart Failure

2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation

J Am Coll Cardiol

Muller DWM, Sorajja P, Duncan A, Bethea B, Dahle G, Grayburn P, Babaliaros V, Guerrero M, Thourani VH, Bedogni F, Denti P, Dumonteil N, Modine T, Jansz P, Chuang ML, Blanke P, Leipsic J, Badhwar V

doi: 10.1016/j.jacc.2021.08.060

Therapy and Intervention

Interventional treatment of mitral valve regurgitation: an alternative to surgery?

Swiss Med Wkly.

Praz F, Brugger N, Kassar M, Hunziker L, Moschovitis A, Stortecky S, Reineke D, Pilgrim T, Windecker S

doi: 10.4414/smw.

Heart, Artery and Coronary Diseases

Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation

J Am Coll Cardiol

Bertrand PB, Overbey JR, Zeng X, Levine RA, Ailawadi G, Acker MA, Smith PK, Thourani VH, Bagiella E, Miller MA, Gupta L, Mack MJ, Gillinov AM, Giustino G, Moskowitz AJ, Gelijns AC, Bowdish ME, O'Gara PT, Gammie JS, Hung J, Cardiothoracic Surgical Trials Network (CTSN).

doi: 10.1016/j.jacc.2020.11.066

Heart, Artery and Coronary DiseasesTherapy and InterventionFurther Publications

Surgery is Not Associated with Improved Survival Compared to Medical Therapy in Isolated Severe Tricuspid Regurgitation

J Am Coll Cardiol.

Axtell AL, Bhambhani V, Moonsamy P, Healy EW, Picard MH, Sundt TM, Wasfy JH

doi: 10.1016/j.jacc.2019.04.028.

Heart, Artery and Coronary Diseases

Twenty-Year Outcome after Mitral Repair Versus Replacement for Severe Degenerative Mitral Regurgitation. Analysis of a Large, Prospective, Multicenter International Registry

Circulation.

Lazam S, Vanoverschelde JL, Tribouilloy C, Grigioni F, Suri RM, Avierinos JF, de Meester C, Barbieri A, Rusinaru D, Russo A, Pasquet AA, Michelena HI, Huebner M, Maalouf J, Clavel MA, Szymanski C, Enriquez-Sarano ME; MIDA investigators

doi: 10.1161/

Heart, Artery and Coronary DiseasesHeart Failure

2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

J Am Coll Cardiol.

O'Gara PT, Grayburn PA, Badhwar V, Afonso LC, Carroll JD, Elmariah S, Kithcart AP, Nishimura RA, Ryan TJ, Schwartz A, Stevenson LW

doi: 10.1016/

Heart, Artery and Coronary Diseases

An Appraisal of the Association of Clinical Outcomes With the Severity of Regurgitant Volume Relative to End-Diastolic Volume in Patients With Secondary Mitral Regurgitation

JAMA Cardiol.

Gaasch WH, Aurigemma GP, Meyer TE

doi: 10.1001/jamacardio.2019.5980.

Heart, Artery and Coronary DiseasesThrombosis and StrokeTherapy and Intervention

Transcatheter Mitral Valve Replacement for Patients With Symptomatic Mitral Regurgitation: A Global Feasibility Trial

J Am Coll Cardiol.

Muller DW, Farivar RS, Jansz P, Bae R, Walters D, Clarke A, Grayburn PA, Stoler RC, Dahle G, Rein KA, Shaw M, Scalia GM, Guerrero M, Pearson P, Kapadia S, Gillinov M, Pichard A, Corso P, Popma J, Chuang M, Blanke P, Leipsic J, Sorajja P; Tendyne Global Feasibility Trial Investigators

doi: 10.1016/j.jacc.2016.10.068.

Related content

Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study

2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation

Interventional treatment of mitral valve regurgitation: an alternative to surgery?

Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation

Surgery is Not Associated with Improved Survival Compared to Medical Therapy in Isolated Severe Tricuspid Regurgitation

Twenty-Year Outcome after Mitral Repair Versus Replacement for Severe Degenerative Mitral Regurgitation. Analysis of a Large, Prospective, Multicenter International Registry

2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

An Appraisal of the Association of Clinical Outcomes With the Severity of Regurgitant Volume Relative to End-Diastolic Volume in Patients With Secondary Mitral Regurgitation

Transcatheter Mitral Valve Replacement for Patients With Symptomatic Mitral Regurgitation: A Global Feasibility Trial